The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multilevel factors impacting clinical trial participation: An ASCO State of Cancer Care in America (SOCCA) analysis of oncology fellows’ perceptions of preparedness to conduct clinical research in practice and importance of clinical trial participation.
 
Ishwaria M. Subbiah
Consulting or Advisory Role - MedImmune (I)
Research Funding - Abbvie (I); Amgen (I); Bayer (I); Blueprint Medicines (I); Celgene (I); Exelixis (I); Fujifilm (I); GlaxoSmithKline (I); Incyte (I); Loxo (I); Multivir (I); NanoCarrier (I); Northwest Biotherapeutics (I); Novartis (I); Pfizer (I); Takeda (I)
 
Caroline Schenkel
No Relationships to Disclose
 
Margaret Kelsey Kirkwood
No Relationships to Disclose
 
Jeffrey M. Peppercorn
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
 
Blase N. Polite
Honoraria - American Journal of Managed Care; Genzyme
Consulting or Advisory Role - Cellicon Biotechnologies; Janssen Oncology
Speakers' Bureau - Natera
Travel, Accommodations, Expenses - Tapestry Pharmaceuticals
 
David Michael Waterhouse
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AZTherapies; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Fresenius Kabi; Gilead Sciences; Janssen Oncology; Jazz Pharmaceuticals; Lilly; McGivney Global Advisors; Merck; Mirati Therapeutics; Pfizer; Sanofi; Sanofi/Regeneron; Seagen
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Janssen Oncology; Merck
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Robin Zon
Stock and Other Ownership Interests - AC3; AstraZeneca; Athenex; crispr therapeutics; Cytosorbents; Johnson & Johnson/Janssen; McKesson; Moderna Therapeutics; Oncolytics; Select Sector SPDR Health Care; TG Therapeutics
Consulting or Advisory Role - Abbvie; Canopy Care; LabCorp; New Century Health; Sanofi
Other Relationship - Cincinnati Cancer Advisors
 
Laura A. Levit
No Relationships to Disclose